Navigation Links
NDRI Has Been Awarded $3.59 Million From the National Institutes of Health, 'The Directors Common Fund' to Provide Human Tissue for 'GTEx,' the New Genotype-Tissue Expression Project
Date:10/13/2010

d rare diseases.  Today, NDRI is the leading national organization that connects donated human tissue with the research scientists who need it to develop new therapies and cures for human disease.  NDRI serves just about every disease.  

About NDRI

NDRI is celebrating its 30th Anniversary year having created the original systems to bring donated human tissue to the scientific community in a continuous way. The nonprofit NDRI (National Disease Research Interchange) was established in 1980 and designed the systems to provide scientists with the human tissue necessary to study human systems and human disease.  In the past 30 years, NDRI has served some 5,000 scientists with more than 300,000 human biomaterials, leading to more than 2,600 papers published in scholarly journals on diseases from diabetes to cancer to HIV and rare diseases.  

Funded in part by the National Institutes of Health (NIH), NDRI provides biomaterials to more than 200 of the nation's most prominent academic-based research centers including the Harvard Medical School, the Massachusetts Institute of Technology, Mt. Sinai School of Medicine, Stanford University, Thomas Jefferson University, and University of Pennsylvania, Wistar, among others.  NDRI also provides tissues to government agencies and grantees including the NIH, the U.S. Food & Drug Administration, the U.S. Department of Agriculture, the Centers for Disease Control and Prevention, and to some of the nation's top pharma, biotech and R&D programs. NDRI has been funded by the National Institutes of Health for 23 consecutive years.

NDRI is a not-for-profit (501c3) corporation. Funding support provided by NIH includes core funding from NCRR, the National Center for Research Resources, with additional funding from NEI, the National Eye Institute, NIDDK, the National Institute of Diabetes and Digestive and Kidney Diseases, NIAID, the National Institute of Allergy an
'/>"/>

SOURCE NDRI, The National Disease Research Interchange
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
2. Federal Funding Awarded to Test Antimicrobial Properties of Copper Metals
3. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
4. Nobel Prize Awarded to Foundation for Biomedical Research Board Member
5. National Jewish, Brigham and Womens Awarded $37 Million to Identify Genes and Other Risk Factors that Influence the Development of COPD
6. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
7. Congressional Funds Awarded for Testing of Antimicrobial Copper Metals
8. DiObex, Inc. Awarded Patent for the Prevention of Insulin-Induced Hypoglycemia
9. Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology
10. New Patent Awarded for Antigen-Sparing Vaccines that Elicit Robust Immunity
11. TriLink Awarded a Phase II Grant for a Second Hot Start PCR Project
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014   Decision Resources Group finds that ... chronic kidney disease non-dialysis (CKD-ND) patients are not ... In addition, one-year persistency is similar between Amgen,s ... key findings from the report entitled ... Stimulating Agents in Late Stage Chronic Kidney Disease ...
(Date:9/30/2014)... Ind. , Sept. 30, 2014  The orthopedic specialists ... the nation,s No. 6 orthopedic group by US News ... Active Adults," a series of free, public seminars to ... all over the world come to see the knee ... procedures are now available at Munster Specialty Surgery Center. ...
(Date:9/30/2014)... In 2011, approximately 5.1 million people in ... pain relievers (e.g. opioids). 1 Clinical treatments for ... the use of buprenorphine, buprenorphine/naloxone, naltrexone or methadone. The ... developing and improving care management programs, according to ... Therapeutics LLC (Prime). Cost trends ...
Breaking Medicine Technology:Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 2Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 3"Knee Pain Solutions for Active Adults" Complimentary Seminars Open to the Public 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 3
... , LITTLE FALLS, N.J., Dec. 2 ... the results for its first quarter ended October 31, 2009 on ... to discuss the results at 11:00 AM ET. Participating in ... President and CEO; Seth R. Segel, Executive Vice President; Craig A. ...
... , , CENTENNIAL, Colo., Dec. 2 ... bone and soft tissue allografts for use in surgical procedures ... substitutes, today announced its sponsorship of a truly iconic symbol ... Life float in the January 1, 2010 Tournament of Roses ...
Cached Medicine Technology:Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2009 2AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 2AlloSource Sponsors Heroic Quadruple Amputee as Rider Aboard 2010 Donate Life Rose Parade Float 3
(Date:9/30/2014)... Health Day Reporter TUESDAY, ... who are overweight or obese when diagnosed appear to ... weight-related cancer, new research suggests. , , The finding ... only the potential for developing other cancers associated with ... who reported being overweight or obese prior to diagnosis ...
(Date:9/30/2014)... Symposia will convene the first conference of its 2014-2015 ... Series on "The Modes of Action of Vaccine ... the conclusion of the Grand Challenges Meeting for that ... Keystone Symposia Global Health Series, supported by the Bill ... awards for 36 investigators from developing countries to attend. ...
(Date:9/30/2014)... Integrated Medicine Alliance , Monmouth County’s ... medical specialty practice through a unique partnership with an ... located within the company’s Shrewsbury location and will be ... of American Heart Center, P.C., a highly regarded practice ... Integrated Medicine Alliance patients top notch cardiovascular care without ...
(Date:9/30/2014)... team has been awarded a three-year $1.7 million ... to develop new imaging technologies and data analysis ... large networks of neurons in the brain interact ... researchers identify the precise interactions between millions of ... speaking, and alterations in these interactions that may ...
(Date:9/30/2014)... Vegas, NV (PRWEB) September 30, 2014 ... is helping people perform better in and out of the ... and memory has caught the attention of Shane Michaels, prompting ... day-to-day grind, fatigue is the reason most people simply just ... whether that means staying focused at work, getting the motivation ...
Breaking Medicine News(10 mins):Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 2Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 3Health News:Keystone Symposia launches 2014-2015 meeting series with Global Health Vaccines Conference 2Health News:Integrated Medicine Alliance Announces New Cardiology Practice 2Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2
... released software program will let health authorities at the ... speeding the detection of new cases and the implementation ... was developed by a team of epidemiologists and computer ... (MIDAS), an international program supported by the National Institutes ...
... Cover Election, Customer Service and Other Work Life Topics ... That Counter Recent ... those,surveyed in the 2007 Annual Work+Life Fit Reality Check believe the ... offer and individuals to have more work life flexibility.,The telephone survey ...
... Avani to Represent Dermatology Products Featuring Invisicare(R), ... Inc. (OTC,Bulletin Board: SKVI) / (Website: ... has signed a marketing agreement with Avani,International ... it was granted a comprehensive patent in ...
... Dec. 6 Insmed Inc. (Nasdaq:,INSM), a developer of ... at the IBC 5th Annual Global Follow-On Biologics,Conference on ... The conference, to be held at the Hyatt Regency ... through Tuesday, December,11th, and will bring together corporate, regulatory, ...
... Health, Inc. (Amex: OPK ),today reported that the ... of wet age-related macular degeneration (wet,AMD), was named one ... III,clinical trials during the third quarter of 2007. The ... to Watch report issued by Thomson,Scientific Inc. Thomson,s industry ...
... you get for the nut,that has everything, including more than ... talking therapy doll?, You can at once give a ... it, their own personal and portable psychotherapist. The,Ask Doctor Chuck ... could,earn you the undying gratitude of the rest of your ...
Cached Medicine News:Health News:New software to aid early detection of infectious disease outbreaks 2Health News:Employees Want the Next President's Agenda to Make Work Life Flexibility Easier for Companies and Individuals 2Health News:Employees Want the Next President's Agenda to Make Work Life Flexibility Easier for Companies and Individuals 3Health News:Employees Want the Next President's Agenda to Make Work Life Flexibility Easier for Companies and Individuals 4Health News:Employees Want the Next President's Agenda to Make Work Life Flexibility Easier for Companies and Individuals 5Health News:Skinvisible Signs Marketing Agreement for India 2Health News:Skinvisible Signs Marketing Agreement for India 3Health News:Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference 2Health News:OPKO's Bevasiranib Named One of Most Promising Drugs Recently Entering Phase III Trials 2Health News:OPKO's Bevasiranib Named One of Most Promising Drugs Recently Entering Phase III Trials 3Health News:OPKO's Bevasiranib Named One of Most Promising Drugs Recently Entering Phase III Trials 4Health News:The Cure for Holiday Stress 2
The fat loss formula's key ingredient of 2.0% aminophylline works by penetrating deep into the skin where it causes the body fat cells to shrink, resulting in up to 2 inches of body fat loss....
... VelaSmooth is the first ... device with the revolutionary elos ... Radio Frequency and Infrared Light ... with suction to reduce the ...
... was designed with the physician, staff ... you the best economy exam room ... does not skimp on patient comfort. ... can easily position patients so that ...
The Salt A-Peel™ microdermabrasion combines, positive air pressure, pure salt, ultrasound and the application of rich anti oxidant products to deliver a remarkable 'The Salt A-Peel' anti ageing...
Medicine Products: